Condition
Tachycardia-induced Cardiomyopathy
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05467163Not ApplicableActive Not Recruiting
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
NCT03388905Not ApplicableUnknownPrimary
Role of the Wearable Cardioverter Defibrillator in Tachycardia Induced Cardiomyopathy
Showing all 2 trials